Podcasts about american colleges

Chegou o episódio escolhido por vocês! Marcela Belleza e Joanne Alves convidam Carol Millon para conversar sobe 6 clinicagens de inibidores de SGLT2, as gliflozinas:Indicações além do DMRisco de CAD euglicêmicaQuando não usar?⁠Cuidados com doença aguda (sick day) e hipovolemia⁠Cuidados pré-operatórioRisco de fratura e amputaçãoReferências:1. Bailey CJ, et al. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Med. 2013;11:43. Published 2013 Feb 20. doi:10.1186/1741-7015-11-432. Bersoff-Matcha SJ, et al. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Ann Intern Med. 2019;170(11):764-769. doi:10.7326/M19-00853. Chang HY, et al. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. JAMA Intern Med. 2018;178(9):1190-1198. doi:10.1001/jamainternmed.2018.3034 4. Clar C, et al. Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open. 2012 Oct 18;2(5):e001007. doi: 10.1136/bmjopen-2012-001007. PMID: 23087012; PMCID: PMC3488745.5. Das SR, et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5. PMID: 32771263; PMCID: PMC7545583. 6. Fralick M, et al. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020;370:m2812. Published 2020 Aug 25. doi:10.1136/bmj.m28127. Li D, et al. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348-355. doi:10.1111/dom.128258. Neal B, et al. Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial. Am Heart J. 2013;166(2):217-223.e11. doi:10.1016/j.ahj.2013.05.0079. Nyirjesy P, et al. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Curr Med Res Opin. 2012;28(7):1173-1178. doi:10.1185/03007995.2012.69705310. Perkovic V, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380(24):2295-2306. doi:10.1056/NEJMoa181174411. Rosenwasser RF, et al. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. PMID: 24348059; PMCID: PMC3848644.12. Sridharan K, Sivaramakrishnan G. Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert Opin Drug Saf. 2025;24(7):797-804. doi:10.1080/14740338.2024.237775513. Ueda P,  et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ. 2018;363:k4365. Published 2018 Nov 14. doi:10.1136/bmj.k436514. Watts NB, et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2016 Jan;101(1):157-66. doi: 10.1210/jc.2015-3167. Epub 2015 Nov 18. PMID: 26580237; PMCID: PMC4701850.15. Zhuo M, et al. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021;4(10):e2130762. Published 2021 Oct 1. doi:10.1001/jamanetworkopen.2021.3076216. Emerson Cestari Marino, Leandra Anália Freitas Negretto, Rogério Silicani Ribeiro, Denise Momesso, Alina Coutinho Rodrigues Feitosa, Marcos Tadashi Kakitani Toyoshima, Joaquim Custódio da Silva Junior, Sérgio Vencio, Marcio Weissheimer Lauria, João Roberto de Sá, Domingos A. Malerbi, Fernando Valente, Silmara A. O. Leite, Danillo Ewerton Oliveira Amaral, Gabriel Magalhães Nunes Guimarães, Plínio da Cunha Leal, Maristela Bueno Lopes, Luiz Carlos Bastos Salles, Liana Maria Torres de Araújo Azi, Amanda Gomes Fonseca, Lorena Ibiapina M. Carvalho, Francília Faloni Coelho, Bruno Halpern, Cynthia M. Valerio, Fabio R. Trujilho,  Antonio Carlos Aguiar Brandão, Ruy Lyra e Marcello Bertoluci. Rastreamento e Controle da Hiperglicemia no Perioperatório – Posicionamento Conjunto da Sociedade Brasileira de Diabetes (SBD), Sociedade Brasileira de Anestesiologia (SBA) e Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica (ABESO). Diretriz Oficial da Sociedade Brasileira de Diabetes (2025). DOI: 10.29327/5660187.2025-10 , ISBN: 978-65-5941-367-6.17. Singh LG, Ntelis S, Siddiqui T, Seliger SL, Sorkin JD, Spanakis EK. Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study. Diabetes Care. 2024;47(6):933-940. doi:10.2337/dc23-112918. Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence. Endocr Pract. 2022;28(9):884-888. doi:10.1016/j.eprac.2022.06.00619. Umapathysivam MM, Morgan B, Inglis JM, et al. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Netw Open. 2024;7(3):e242744. Published 2024 Mar 4. doi:10.1001/jamanetworkopen.2024.274420. Fleming N, Hamblin PS, Story D, Ekinci EI. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors. J Clin Endocrinol Metab. 2020;105(8):dgaa200. doi:10.1210/clinem/dgaa20021. Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854. doi:10.1016/S2213-8587(19)30256-622. Braunwald E. Gliflozins in the Management of Cardiovascular Disease. N Engl J Med. 2022;386(21):2024-2034. doi:10.1056/NEJMra211501123. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa150472024. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med. 2017;377(7):644-657. doi:10.1056/NEJMoa161192525. Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347-357. doi:10.1056/NEJMoa181238926. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995-2008. doi:10.1056/NEJMoa191130327. Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-1424. doi:10.1056/NEJMoa202219028. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa210703829. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383(15):1436-1446. doi:10.1056/NEJMoa202481630. The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, et al. Empagliflozin in...

 Fertility Docs Uncensored is hosted by Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center. In this episode, the docs welcome visiting physician Dr. Shelley Dolitsky from Shady Grove Fertility in Towson, Maryland, for an in-depth conversation about recurrent pregnancy loss. Dr. Dolitsky begins by reviewing how different professional organizations define recurrent pregnancy loss. The American Society for Reproductive Medicine considers two or more losses—including very early biochemical losses—to be recurrent pregnancy loss, while the American College of OB/GYN defines it as two clinical losses under 20 weeks. The docs discuss how age dramatically affects miscarriage risk, with up to 75% of women over 40 experiencing miscarriages, compared with an overall rate of three to five percent. They walk through the full evaluation, which includes assessing the uterine cavity for abnormalities such as scar tissue, polyps, or congenital malformations; ensuring the fallopian tubes are normal and ruling out tubal damage; and performing chromosome analysis on both partners. Testing for antiphospholipid antibodies and lupus anticoagulant is also essential, as these can contribute to placental clotting issues. The conversation highlights the importance of screening for chronic medical issues that might be undiagnosed. About half of patients with recurrent pregnancy loss will have an identifiable and often treatable cause. Finally, the team discusses recommendations for patients whose workup is normal but who continue to experience losses. This podcast was sponsored by Shady Grove Fertility. 

It's YOUR time to #EdUp with Dr. Eric Klein, Assistant Provost, Doctoral Research & Student Success, American College of EducationIn this episode, part of our Academic Integrity Series, sponsored by ⁠Integrity4EducationYOUR cohost is Thomas Fetsch, CEO, Integrity4EducationYOUR host is ⁠Elvin Freytes⁠How does an online university grow enrollment by doubling every year for 5 years while maintaining 85% graduation rates & 95% student satisfaction without raising tuition since 2016?What happens when an institution refuses Title IV funding & offers master's degrees for under $10,000 & doctoral programs under $25,000 while delivering $19.20 in ROI for every $1 students invest?How does a focus on transparency & student centeredness through personalized pathways, immersive VR learning & clear job placement data prepare 12,000 students for lifelong learning in an AI enabled world?Listen in to #EdUpThank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠& ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dr. Joe Sallustio⁠⁠⁠⁠⁠● Join YOUR EdUp community at ⁠The EdUp Experience⁠We make education YOUR business!P.S. Want to get early, ad-free access & exclusive leadership content to help support the show? Then ⁠⁠​subscribe today​⁠⁠ to lock in YOUR $5.99/m lifetime supporters rate! This offer ends December 31, 2025!

What if the key to self-advocacy wasn't being louder—but rewiring how you think, feel, and connect with empathy?Today, I'm joined by executive coach and podcast host Jamie Lee, who specializes in helping women and underrepresented leaders rise through the ranks without compromising their integrity. We dive into how empathy and neuroplasticity form the foundation of effective self-advocacy — and how rewiring internal narratives can lead to greater confidence, deeper connection, and clarity when speaking up. Jamie shares evidence-based techniques for regulating the nervous system so you can show up with presence and poise in high-stakes conversations. Plus, we touch on the six types of intelligence you can access to build connections and ask for what you want.If you've ever struggled with self-advocacy or want to communicate with more impact and empathy, this episode is for you.To access the episode transcript, go to www.TheEmpathyEdge.com, search by episode title.Listen in for…Defining self-advocacy and neuroplasticity in terms of empathy. Compassion as an action is the key to rewiring your brain. Ways to access your parasympathetic nervous system in your thinking brain and get out of your automatic stress response.Leveraging mirror neurons with empathy and compassion. "The brain adapts. The brain grows. It changes according to the practices that you expose it to. Compassion is the missing link that helps us be able to access those self-advocacy muscles for ourselves." — Jamie Lee Episode References: Book a free hour-long consultation for 1:1 coaching with Jamie: https://www.jamieleecoach.com/applyThe Empathy Edge podcast: Dia Bondi: How to Ask Like an AuctioneerMelissa Tiers' Anti-Anxiety Toolkit: https://www.amazon.com/Anti-Anxiety-Toolkit-Melissa-Tiers-ebook/dp/B0073HU3EGJames Tripp's website: https://www.jamestripp.onlineAbout Jamie Lee, Coach, Trainer, Podcast Host Jamie is an executive coach who specializes in women and underrepresented leaders who are "allergic" to office politics. She focuses on helping them get promoted and better paid without compromising their integrity or throwing anyone under the bus. In her practice, she blends proven self-advocacy strategies with evidence-based neuroplasticity tools.Over a decade, Jamie has trained thousands of professionals in effective self-advocacy at leading organizations, including Citi, Unilever, Association of Corporate Counselors, American College of Cardiologists, UC Berkeley School of Business, and Smith College.She's also the host of the Risky Conversations podcast, where she has honest talks with thought leaders on topics often considered taboo or "too risky" at work -- negotiation, mental and reproductive health, office politics, social injustices, and unconventional ways smart women navigate their path forward despite a flawed workplace. From Our Sponsor:Keynote Speakers and Conference Trainers: Get your free Talkadot trial and enjoy this game-changer for your speaking business! www.share.talkadot.com/mariaross Connect with Jamie:Jamie Lee Coach: jamieleecoach.com LinkedIn: linkedin.com/in/leejieunjamie Instagram: instagram.com/jamieleecoach Connect with Maria:Get Maria's books: Red-Slice.com/booksHire Maria to speak: Red-Slice.com/Speaker-Maria-RossTake the LinkedIn Learning Courses! Leading with Empathy and Balancing Empathy, Accountability, and Results as a Leader LinkedIn: Maria RossInstagram: @redslicemariaFacebook: Red SliceKeynote Speakers and Conference Trainers: Get your free Talkadot trial and enjoy this game changer for your speaking business! www.share.talkadot.com/mariarossGet your copy of The Empathy Dilemma here- www.theempathydilemma.com

Soul Food That's Good for the Soul The best of soul food's origins are tied to the plant-centric West African diet. And that's soul food that's good for the soul! Listen to today's 7-min episode by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #Plantbasednutrition #veganpodcast #plantbasedpodcast #plantbasedbriefing #nutritionfacts #wfpb #soulfood #blackvegan #vegansoulfood ===================== Original post: https://nutritionfacts.org/video/soul-food-thats-good-for-the-soul/  ====================== Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity.   FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

Visit ⁠⁠⁠https://longevitybuilders.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠to discover book and The Longevity Builder Health Lab.Episode SummaryFor decades, the standard medical advice for cancer patients was simple: "Rest. Take it easy. Avoid exertion." Today's guest has spent her career proving that advice is not just outdated—it is dangerous.In this episode, Shane Stubbs sits down with Dr. Kathryn Schmitz, the world's leading authority in Exercise Oncology. Dr. Schmitz is the scientist who literally wrote the book on moving through cancer. She spearheaded the "Exercise is Medicine" initiative and has led over $30 million in research funding to prove that exercise changes the biology of cancer.We dive deep into why building a resilient body is your best defense, the specific "Move, Lift, Eat, Sleep, Log" framework, and how resistance training impacts survivorship.PLUS: Stay tuned until the very end for a "Science Spotlight" Bonus Segment. Shane breaks down new research highlighted by Dr. Rhonda Patrick on "Shear Stress"—explaining the physics of how vigorous exercise can mechanically destroy circulating tumor cells and reverse heart aging by 20 years.The Paradigm Shift: Why the old advice to "rest" during cancer treatment is being replaced by a prescription for movement.The Science: Dr. Schmitz's $30M+ research journey and her role in writing the ACSM guidelines for cancer survivors.The Protocol: The "Move, Lift, Eat, Sleep, Log" framework for building a body that can withstand the "Big Four" (Cancer, Heart Disease, Metabolic Dysfunction, Neurodegeneration).Exercise as Medicine: How specific doses of activity can alleviate symptoms, improve chemotherapy tolerance, and boost survival rates.BONUS Segment: The physics of Shear Stress. We discuss Dr. Rhonda Patrick's breakdown of how high-intensity blood flow can kill Circulating Tumor Cells (CTCs) and scrub your arteries.Dr. Kathryn Schmitz is a Distinguished Professor of Public Health Sciences and a Professor of Physical Medicine and Rehabilitation. A trailblazer in the field of Exercise Oncology, she served as the President of the American College of Sports Medicine (ACSM) and founded the Moving Through Cancer initiative.With a PhD in Exercise Physiology, an MPH in Epidemiology, and over 300 peer-reviewed scientific papers, Dr. Schmitz is the foremost voice on the intersection of movement and malignancy. She is the author of the book Moving Through Cancer.Book: Moving Through Cancer by Dr. Kathryn SchmitzInitiative: Moving Through Cancer (ACSM)Research Spotlight: Dr. Rhonda Patrick on Shear Stress & Circulating Tumor CellsReady to put this science into practice? Don't just listen—execute.Join the Longevity Builder Health Lab to access the protocols, community, and tools you need to build a body that lasts.

This episode features C. William Schwab, MD, FACS, FRCS, a retired US Navy Commander from Philadelphia, who is among the growing number of trauma surgeons urging national trauma readiness. During the Edward D. Churchill Lecture at the American College of Surgeons (ACS) Clinical Congress in Chicago, Dr. Schwab said that the US healthcare system's ability to respond to mass casualty events, including warfare-related injuries, is predicated on the preparedness of every surgeon and hospital system.   Talk about the podcast on social media using the hashtag #HouseofSurgery.  

Att hantera jodkontrast för våra njursjuka patienter har länge varit en arbetsuppgift som krävt mycket tid och tankemöda. Men på sista tiden har förändringens vindar börjat blåsa, och möjligen ser vi ett paradigmskifte. Det kanske inte är så farligt att ge kontrast till patienter med njursvikt trots allt? Vad säger egentligen vetenskapen om korrelation och kausalitet? Vi intervjuar nefrologen Carin Wallquist som är på korståg mot fenomenet Renalism, och som ger oss en mycket ambitiös genomgång av kunskapsläget. Artiklar som nämns i avsnittet: McDonald JS, McDonald RJ. Risk of Acute Kidney Injury Following IV Iodinated Contrast Media Exposure: 2023 Update, From the AJR Special Series on Contrast Media. AJR Am J Roentgenol. 2024 Jul;223(1):e2330037. doi: 10.2214/AJR.23.30037. Epub 2024 Oct 4. PMID: 37791729. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008 Aug;191(2):376-82. doi: 10.2214/AJR.07.3280. PMID: 18647905. Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV Jr, Nakhoul GN. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis. Nephron. 2019;141(1):31-40. doi: 10.1159/000494047. Epub 2018 Oct 26. PMID: 30368506. Choi B, Heo S, Mcdonald JS, Choi SH, Choi WM, Lee JB, Lee EA, Park SH, Seol S, Gan S, Park B, Choi HJ, Kim BJ, Rhee SY, Hong SB, Kim KH, Lee YH, Kim SS, Park RW. Risk of Contrast-Induced Acute Kidney Injury in Computed Tomography: A 16 Institutional Retrospective Cohort Study. Invest Radiol. 2025 Jun 1;60(6):376-386. doi: 10.1097/RLI.0000000000001141. Epub 2024 Nov 28. PMID: 39602881. Ehmann MR, Mitchell J, Levin S, Smith A, Menez S, Hinson JS, Klein EY. Renal outcomes following intravenous contrast administration in patients with acute kidney injury: a multi-site retrospective propensity-adjusted analysis. Intensive Care Med. 2023 Feb;49(2):205-215. doi: 10.1007/s00134-022-06966-w. Epub 2023 Jan 30. PMID: 36715705. Berglund F, Eilertz E, Nimmersjö F, Wolf A, Nordlander C, Palm F, Parenmark F, Westerbergh J, Liss P, Frithiof R. Acute and long-term renal effects after iodine contrast media-enhanced computerised tomography in the critically ill-a retrospective bi-centre cohort study. Eur Radiol. 2024 Mar;34(3):1736-1745. doi: 10.1007/s00330-023-10059-7. Epub 2023 Sep 2. PMID: 37658144; PMCID: PMC10873227. Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, Rodby RA, Wang CL, Weinreb JC. Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020 Mar;294(3):660-668. doi: 10.1148/radiol.2019192094. Epub 2020 Jan 21. PMID: 31961246. Chotkan KA, Hilbrands LB, Putter H, Konjin C, Schaefer B, Beenen LFM, Pol RA, Braat AE. Transplant Outcomes After Exposure of Deceased Kidney Donors to Contrast Medium. Transplantation. 2024 Jan 1;108(1):252-260. doi: 10.1097/TP.0000000000004745. Epub 2023 Sep 6. PMID: 37728569; PMCID: PMC10718213. Nijssen EC, Nelemans PJ, Rennenberg RJ, Theunissen RA, van Ommen V, Wildberger JE. Prophylaxis in High-Risk Patients With eGFR < 30 mL/min/1.73 m2: Get the Balance Right. Invest Radiol. 2019 Sep;54(9):580-588. doi: 10.1097/RLI.0000000000000570. PMID: 31033672. ===== Akutradiologikursens hemsida: www.akutradiologikursen.se Avsnittet presenteras i samarbete med Teleconsult. Läs mer om vad de kan erbjuda dig som radiolog, eller dig som chef på en underbemannad röntgenavdelning, på www.teleconsult.net !

Lee el blogpost completo: https://ecctrainings.com/cuidado-de-quemaduras-en-zonas-remotas-versus-combate-lecciones-cruzadas-entre-las-guias-jts-y-wms Únete al ECCnetwork en Circle: Sé parte de la comunidad que transforma la educación en emergencias. Activa tu membresía gratuita y accede a contenido exclusivo, foros y eventos. 

Vaccines are one of public health's greatest success stories—but what happens when people start saying no? In this episode, Kevin and Dr. Lisa Wolf dig into the rising tide of vaccine refusal, what's fueling it, and how it's already impacting what we see in the emergency department.  If you've ever struggled to explain vaccine science to a skeptical patient, this episode is essential listening. Resources mentioned: ·       American Academy of Pediatrics vaccination recommendations ·       American College of Obstetricians and Gynecologists vaccine guidelines ·       Studies on shingles vaccine and dementia reduction ·       HPV vaccine and cervical cancer elimination in Scotland ·       Vaccination in the emergency department study Follow us on: Facebook: https://www.facebook.com/Art-of-Emergency-Nursing-276898616569046/  YouTube: https://www.youtube.com/channel/UCJTnz4phtCTjojTIDJo2afA?view_as=subscriber  Twitter: @AoenPodcast Instagram: https://www.instagram.com/artofemergencynursing/  To support the show: Leave an honest review on iTunes. Your ratings and reviews greatly contribute to the success of the podcast, and I appreciate each and every one of them. Subscribe on Apple Podcasts, Google Podcasts, or your preferred podcast platform to never miss an episode. Thank you for being a part of our AOEN community!

In this episode, Becky sits down with Patrick McLaughlin, award-winning author of Cheerful Obedience: A Novel, U.S. Army veteran, Ohio Veterans Hall of Fame inductee, and retired fellow of the American College of Trial Lawyers. Patrick shares how his early life, military service, and career in law shaped his perspective as a storyteller. He reveals the inspirations behind his debut novel, how he chose the striking title Cheerful Obedience, and why he believes readers have connected so deeply with the book—earning it multiple national awards. The conversation explores the themes at the heart of his work: moral duty, personal sacrifice, and the complexities of living with integrity. Patrick discusses the real-world issues his book addresses, the impact he hopes to create for readers, and what it means to bring authenticity and emotional truth into fiction.   Whether you're a fan of character-driven fiction, military-inspired stories, or the craft of writing itself, this episode offers a rich and thoughtful conversation with an author whose life experience deeply informs his art. Visit AMPlify Audiobooks to explore Cheerful Obedience and learn more about Patrick McLaughlin's work.

Doctor Mau Informa ®️#drmauinforma 

Host Dr. Joe Patterson sits down with Drs. Michael Sutherland, Bryant Oliphant, and Jennifer Hagen to talk about the American College of Surgeons Committee on Trauma and how orthopedic trauma surgeons can get involved and benefit from the organization in daily practice. Live from the OTA 2025 Annual Meeting. For more information and to become an ACS member, click here. For additional educational resources visit OTA.org  

Welcome to the Legal Nurse Podcast, where complex medical topics meet the world of litigation. In this episode, host Pat Iyer sits down with Dr. Allison Muller, a seasoned toxicologist who brings her expertise to the forefront of the ongoing opioid crisis. Together, they delve into the multifaceted role opioids play in patient care, legal cases, and toxicology, offering invaluable insights for legal nurse consultants and medical professionals alike. Throughout their conversation, Pat Iyer and Allison Muller unpack the intricacies of opioid administration, the significance of accurate medical record documentation, and the challenges of interpreting toxicology reports, especially in postmortem cases. Dr. Muller sheds light on key concepts such as opioid tolerance versus naivety, risks of over-sedation, and the life-saving but often misunderstood role of naloxone in reversing opioid overdoses. Whether you're navigating your first toxicology-related case or looking to deepen your understanding of opioid implications in acute care settings, this episode offers practical guidance and real-world examples. From common pitfalls in toxicology interpretation to the criteria for bringing a toxicologist onto your legal team, Dr. Muller and Pat Iyer provide a roadmap for safer patient care and stronger case outcomes. What you'll learn in this episode on Navigating Opioid Cases: Insights from a Toxicologist on Medical Records and Overdose Risks Here are five intriguing questions that this podcast answers: How should medical records be reviewed to accurately track opioid administration in acute care settings, and what are the limitations of toxicology blood levels in this context? Why do toxicology reports from autopsies take so long to be completed, and what complexities are involved in determining the substances present in a decedent's system? What is the difference between opioid naive and opioid tolerant patients, and why is understanding these distinctions critical for safe opioid prescribing? What are the best practices for administering Naloxone (Narcan) in cases of opioid overdose, and why is timing so crucial for its effectiveness? When is it appropriate for a legal nurse consultant to recommend involving a toxicologist in a case, especially when interpreting complex toxicology results? Listen to our podcasts or watch them using our app, Expert.edu, available at legalnursebusiness.com/expertedu. Get the free transcripts and also learn about other ways to subscribe. Go to Legal Nurse Podcasts subscribe options by using this short link: http://LNC.tips/subscribepodcast. Grow Your LNC Business 13th LNC SUCCESS® ONLINE CONFERENCE April 23, 24, and 25, 2026 Skills, Strategy, Results Gain deposition mastery, marketing confidence, and clinical–legal insight from industry leaders you can apply to your next case and client call. Build a Practice Attorneys Remember Learn exactly how to showcase expertise, attract referrals, and turn complex medical records into clear, defensible stories that win trust. Learn From the Best—Then Ask Them Anything Get step-by-step training, live “hot seat” solutions, and exclusive VIP Q&A time with Pat Iyer to accelerate your LNC growth. Register now- Limited spots available Your Presenters for Navigating Opioid Cases: Insights from a Toxicologist on Medical Records and Overdose Risks Pat Iyer Pat Iyer is a seasoned legal nurse consultant and business coach renowned for her expertise in guiding new legal nurse consultants to successfully break into the field. As the host of the Legal Nurse Podcast, Pat addresses critical challenges that legal nurse consultants face, such as difficulty in landing clients and lack of response from attorneys. Through her insightful episodes, she emphasizes the importance of effectively communicating one's value to potential clients. With a wealth of experience, Pat has empowered countless consultants to overcome these hurdles and thrive in their careers. Connect with Pat Iyer by email at patiyer@legalnusebusiness.com Allison Muller Toxicologist with a passion for science, family, and the outdoors. Board-certified clinical toxicologist, fellow of the American Academy of Clinical Toxicology, affiliate fellow of the American College of Medical Toxicology, and faculty at the University of Pennsylvania School of Veterinary Medicine. Scientist with a flair for explaining the hard stuff to the triers of fact and anyone who wants to learn toxicology! When she isn't on this podcast, she's caring for an orange tabby cat and a dwarf bunny (luckily the tabby doesn't know his best friend is a bunny!) Connect with Allison Muller by email at Allison@AcriMullerConsulting.com

Common Form 709 mistakes can trigger costly GST and gift-tax consequences. ACTEC experts explain how to spot and fix DSUE, GST allocation, and gift-splitting errors. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.

Moins connue que la ménopause, l'andropause est une période au cours de laquelle la sécrétion de testostérone diminue chez l'homme. Baisse de la libido, fatigue, augmentation du risque cardiovasculaire, irritabilité, augmentation du tour de taille… Les symptômes de l'andropause sont nombreux. Contrairement à la ménopause qui touche toutes les femmes, l'andropause n'affecte qu'une faible proportion d'hommes âgés. Comment se fait le diagnostic ? Quelle prise en charge existe ?  Si, du côté des femmes, les effets et ressentis associés à la ménopause sont abordés plus ouvertement qu'il y a quelques années, chez les hommes, l'andropause reste encore largement méconnue et rarement évoquée publiquement. Pourtant, les changements hormonaux liés au vieillissement impliquent un certain nombre de conséquences pour la santé et le bien-être des hommes. La baisse du taux de testostérone peut entraîner de multiples symptômes.  Andropause : ménopause au masculin ?  Certains spécialistes (urologue, endocrinologue, andrologue...) peuvent orienter le patient vers des analyses pour évaluer le taux de testostérone sanguin. La chute des androgènes peut provoquer une série de symptômes tels que des troubles de la fonction érectile, une baisse de la libido, une prise de poids, des troubles de l'humeur et du sommeil… Alors si certains symptômes se retrouvent chez l'homme et la femme, passé un certain âge, ménopause et andropause se distinguent par un simple fait : son caractère systématique chez la femme, autour de la cinquantaine (avec l'arrêt des règles, qui annonce la fin de la fonction reproductrice), quand, chez l'homme, ce déficit d'hormones sexuelles mâles lié à l'âge n'est pas systématique.  En finir avec le non-dit  La prise en charge de l'andropause repose sur des mesures hygiéno-diététiques : activité physique, alimentation équilibrée, baisse de la consommation d'alcool... Pour certains hommes, une supplémentation en testostérone pourra être prescrite, associée à un suivi médical. D'où l'importance de dépasser le tabou : oser en parler, pour trouver, si besoin, des solutions auprès d'un spécialiste.  Avec : Pr François Desgrandchamps, chef du service d'Urologie de l'Hôpital Saint-Louis de Paris, et professeur d'Urologie, à l'Université Paris Cité.   Dr Oumar Gaye, urologue-andrologue au Centre Hospitalier National Dalal Jamm, à Dakar, au Sénégal.   Un reportage de Raphaëlle Constant.  ► En fin d'émission, nous faisons un point sur l'étude de l'Inserm à Paris, publiée dans The Journal of the American College of Cardiology qui fait état du fardeau que représente l'hypertension artérielle en Afrique subsaharienne. Interview du Dr Aboubakari Nambiema, chercheur en Santé publique à l'Inserm au Centre de recherche cardiovasculaire de Paris et au sein de l'Unité de Recherche en Santé des Populations (URESAP) à Lomé au Togo.  Programmation musicale : ► Olivia Dean - Man I need ► Lëk Sèn - Shine.

Moins connue que la ménopause, l'andropause est une période au cours de laquelle la sécrétion de testostérone diminue chez l'homme. Baisse de la libido, fatigue, augmentation du risque cardiovasculaire, irritabilité, augmentation du tour de taille… Les symptômes de l'andropause sont nombreux. Contrairement à la ménopause qui touche toutes les femmes, l'andropause n'affecte qu'une faible proportion d'hommes âgés. Comment se fait le diagnostic ? Quelle prise en charge existe ?  Si, du côté des femmes, les effets et ressentis associés à la ménopause sont abordés plus ouvertement qu'il y a quelques années, chez les hommes, l'andropause reste encore largement méconnue et rarement évoquée publiquement. Pourtant, les changements hormonaux liés au vieillissement impliquent un certain nombre de conséquences pour la santé et le bien-être des hommes. La baisse du taux de testostérone peut entraîner de multiples symptômes.  Andropause : ménopause au masculin ?  Certains spécialistes (urologue, endocrinologue, andrologue...) peuvent orienter le patient vers des analyses pour évaluer le taux de testostérone sanguin. La chute des androgènes peut provoquer une série de symptômes tels que des troubles de la fonction érectile, une baisse de la libido, une prise de poids, des troubles de l'humeur et du sommeil… Alors si certains symptômes se retrouvent chez l'homme et la femme, passé un certain âge, ménopause et andropause se distinguent par un simple fait : son caractère systématique chez la femme, autour de la cinquantaine (avec l'arrêt des règles, qui annonce la fin de la fonction reproductrice), quand, chez l'homme, ce déficit d'hormones sexuelles mâles lié à l'âge n'est pas systématique.  En finir avec le non-dit  La prise en charge de l'andropause repose sur des mesures hygiéno-diététiques : activité physique, alimentation équilibrée, baisse de la consommation d'alcool... Pour certains hommes, une supplémentation en testostérone pourra être prescrite, associée à un suivi médical. D'où l'importance de dépasser le tabou : oser en parler, pour trouver, si besoin, des solutions auprès d'un spécialiste.  Avec : Pr François Desgrandchamps, chef du service d'Urologie de l'Hôpital Saint-Louis de Paris, et professeur d'Urologie, à l'Université Paris Cité.   Dr Oumar Gaye, urologue-andrologue au Centre Hospitalier National Dalal Jamm, à Dakar, au Sénégal.   Un reportage de Raphaëlle Constant.  ► En fin d'émission, nous faisons un point sur l'étude de l'Inserm à Paris, publiée dans The Journal of the American College of Cardiology qui fait état du fardeau que représente l'hypertension artérielle en Afrique subsaharienne. Interview du Dr Aboubakari Nambiema, chercheur en Santé publique à l'Inserm au Centre de recherche cardiovasculaire de Paris et au sein de l'Unité de Recherche en Santé des Populations (URESAP) à Lomé au Togo.  Programmation musicale : ► Olivia Dean - Man I need ► Lëk Sèn - Shine.

Monday, December 8th, 2025Today, Brian Cole confessed to planting the pipe bombs the night before the insurrection and is a MAGA election denier; the developer of the ICE Block app is suing officials from DHS ICE DOJ and the White House; the DOJ is considering taking a third swipe at getting a grand jury to indict NYAG Letitia James; the Government Accountability Office is investigating Bill Pulte - the guy who made all the mortgage fraud referrals to DOJ; the Indiana House advances it's 9-0 map to the Senate; the DOJ has already started stonewalling judge Boasberg in his contempt proceedings against against government officials; Rep Adelita Grijalva was pepper sprayed by ICE after identifying herself as a Congresswoman; Kash Patel ordered a tactical SWAT guy to give his girlfriend's drunk pal a ride home; an internal BOP memo halts rape protections for trans inmates; the Department of Health and Human Services deadnamed an official on her portrait; a judge has ordered the unsealing of Epstein grand jury materials; and Allison and Dana deliver and your Good News.Guest: Joshua Aaron of ICEBlock apphttps://www.iceblock.apphttps://bsky.app/profile/joshua.stealingheather.comhttps://www.tixeconsulting.comGuest: Deirdre von DornumProminent federal criminal defense attorney - 23 years at Federal Defenders of New York - Attorney-in-Charge for the Eastern District; Fellow of the American College of Trial Lawyers. Specializing in complex federal cases, indigent defense, civil rights, and pro bono work.https://www.youtube.com/@MSWMediaPodsStoriesDrag queen Pattie Gonia completes 100-mile trek raising $1m to make outdoors more ‘equitable' | California | The GuardianRep. Adelita Grijalva says she was 'sprayed in the face' during ICE confrontation | NBC NewsIndiana House GOP advances 9-0 congressional map, sending contentious plan to state Senate | CBS NewsPipe bomb suspect confesses and has expressed support for Trump, sources say | MS NOWKash Patel ordered FBI detail to give girlfriend's pal a lift home: sources | MS NOWDOJ won't say what it advised Noem amid contempt inquiry over El Salvador deportations | ABC NewsHHS changed the name of transgender health leader on her official portrait | NPR NewsGovernment Accountability Office opens investigation into FHFA chief Bill Pulte | NBC NewsDOJ orders prison inspectors to stop considering LGBTQ safety standards | NPRJudge orders unsealing of grand jury transcripts from Epstein case in Florida | CBS NewsGood Troublehttps://near.tl/sm/ik-ZushRaEllen She/HerRhode Island continues to fight ICE. Ice vehicles are routinely spotted parked near or circling the courthouse. A WhatsApp text goes out to be present and witness/ hopefully prevent ice kidnappings. If you are a RI local, please sign up. If not, your community likely has something similar.Ice Watch RI WhatsApp channel:‎Follow the Alerta de Migra / ICE Watch RI channel on WhatsApp: https://whatsapp.com/channel/0029VbBK6Y229759BqNu3p2mPROTECT YOURSELF AND YOUR COMMUNICATIONS WHEN USING WHATSAPP:https://securityinabox.org/en/tools/whatsappFront Line Defenders:https://www.frontlinedefenders.org/enJoin Dana and The Daily Beans and support on Giving Tuesdayhttp://onecau.se/_ekes71From The Good Newshttps://www.aafront.org/fbklivehttps://www.mprnews.org/story/2025/12/02/escalation-of-rhetoric-from-white-house-targeting-somalis-is-unhinged-says-somali-scholarhttps://www.summitdogrescue.org/meet-fressi--fresita.html→Please submit your own at https://DailyBeansPod.com - click on ‘Good News and Good Trouble'Our Donation Linkshttps://www.nationalsecuritylaw.org/donate, https://secure.actblue.com/donate/msw-bwc, http://WhistleblowerAid.org/beansFederal workers - email AG at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen.Dr. Allison Gill - https://muellershewrote.substack.com, https://bsky.app/profile/muellershewrote.com, https://instagram.com/muellershewrote, https://twitter.com/MuellerSheWrote, https://www.youtube.com/@MSWMediaPodsDana Goldberg - https://bsky.app/profile/dgcomedy.bsky.social, https://twitter.com/DGComedy, https://www.instagram.com/dgcomedy, https://www.facebook.com/dgcomedy, https://danagoldberg.comMore from MSW Media - https://mswmedia.com/shows, Cleanup On Aisle 45 pod, https://muellershewrote.substack.comReminder - you can see the pod pics if you become a Patron. The good news pics are at the bottom of the show notes of each Patreon episode! That's just one of the perks of subscribing! patreon.com/muellershewrote Our Donation LinksNational Security Counselors - DonateMSW Media, Blue Wave California Victory Fund | ActBlueWhistleblowerAid.org/beansFederal workers - feel free to email AG at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen. Find Upcoming Actions 50501 Movement, No Kings.org, Indivisible.orgDr. Allison Gill - Substack, BlueSky , TikTok, IG, TwitterDana Goldberg - BlueSky, Twitter, IG, facebook, danagoldberg.comCheck out more from MSW Media - Shows - MSW Media, Cleanup On Aisle 45 pod, The Breakdown | SubstackShare your Good News or Good TroubleMSW Good News and Good TroubleHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?The Daily Beans | SupercastThe Daily Beans & Mueller, She Wrote | PatreonThe Daily Beans | Apple Podcasts Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Contributor: Aaron Lessen, MD Educational Pearls: How do amiodarone and lidocaine work on the heart? Amiodarone Blocks potassium channels (Class III effect). Also blocks sodium and calcium channels. Additional noncompetitive beta-blocker effects. Stabilizes cardiac tissue, slows heart rate, and suppresses both atrial and ventricular arrhythmias. Lidocaine Blocks fast sodium channels in ventricular tissue (Class Ib). Shortens the action potential in ventricular myocardium, especially in ischemic tissue. Suppresses abnormal automaticity in damaged/irritable myocardium. Which one should you pick for a patient in vtach/vfib cardiac arrest? The current guidelines recommend amiodarone for shock-refractory cases but this is based on randomized trials showing better arrhythmia termination and short-term outcomes, but not long-term survival benefits. Two recent studies suggest that lidocaine might actually be preferable. A 2023 paper published in Chest Performed a large retrospective cohort study for treating in-hospital VT/VF cardiac arrest. Among more than 14,000 patients, lidocaine was associated with higher rates of ROSC, 24-hour survival, survival to discharge, and favorable neurologic outcomes. These results held after adjusting for covariates and using propensity score methods. Overall, lidocaine outperformed amiodarone across all major clinical outcomes in this population. A 2025 paper published in Resuscitation Performed a target trial emulation in adults with out-of-hospital shockable cardiac arrest. After propensity score matching in more than 23,000 eligible cases, lidocaine was associated with higher odds of prehospital ROSC, fewer post-drug defibrillations, and greater survival to hospital discharge. These advantages were consistent across matched patient pairs. Dose for lidocaine is an initial 1-1.5 mg/kg IV bolus, followed by additional boluses of 0.5-0.75 mg/kg every 5-10 minutes up to a total of 3 mg/kg if needed. Dose for amiodarone is a 300 mg bolus followed by an additional 150 mg bolus if needed. References Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018 Oct;15(10):e190-e252. doi: 10.1016/j.hrthm.2017.10.035. Epub 2017 Oct 30. Erratum in: Heart Rhythm. 2018 Nov;15(11):e278-e281. doi: 10.1016/j.hrthm.2018.09.026. PMID: 29097320. Smida T, Crowe R, Price BS, Scheidler J, Martin PS, Shukis M, Bardes J. A retrospective 'target trial emulation' comparing amiodarone and lidocaine for adult out-of-hospital cardiac arrest resuscitation. Resuscitation. 2025 Mar;208:110515. doi: 10.1016/j.resuscitation.2025.110515. Epub 2025 Jan 23. PMID: 39863130; PMCID: PMC11908894. Wagner D, Kronick SL, Nawer H, Cranford JA, Bradley SM, Neumar RW. Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Chest. 2023 May;163(5):1109-1119. doi: 10.1016/j.chest.2022.10.024. Epub 2022 Nov 2. PMID: 36332663. Summarized by Jeffrey Olson, MS4 | Edited by Jeffrey Olson and Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462 Overview: In this episode, we examine migraine—a leading cause of disability worldwide that is often underdiagnosed and undertreated in primary care. You'll learn how to distinguish migraine from other headache disorders, identify who is most affected, and explore both acute pharmacologic options and preventive strategies that can reduce attack frequency and improve patients' quality of life. Episode resource links: El Hussein, M. T., & Fraser, L. (2025). Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide. The Journal for Nurse Practitioners, 21(9), 105501. Qaseem, A., Tice, J. A., Etxeandia-Ikobaltzeta, I., Wilt, T. J., Harrod, C. S., Cooney, T. G., ... & Yost, J. (2025). Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guideline from the American College of Physicians. Annals of internal medicine, 178(4), 571-578. Charles, A. C., Tepper, S. J., & Ailani, J. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache: The Journal of Head and Face Pain. Vélez-Jiménez MK, et al. Comprehensive Preventive Treatments for Episodic Migraine: Systematic Review. Front Neurol. 2025 Lanteri-Minet, M., Casarotto, C., Bretin, O., Collin, C., Gugenheim, M., Raclot, V., ... & Lefebvre, H. (2025). Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. The Journal of Headache and Pain, 26(1), 153. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

For this episode hosts Drew, Tanner, and Andy are joined by performance scientist Jason Brooks to discuss the topic of Mental Interference. Do't forget we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org to learn more about this organization and how you can attend a future CME event!

(0:00) Intro(1:21) About the podcast sponsor: The American College of Governance Counsel(2:08) Start of interview(2:36) Michelle's origin story(4:33) The Origins of Footnoted (started in 2003)(6:36) Understanding SEC Filings and Disclosures(7:20) The "Friday Night Dump"(9:34) The State of Public vs. Private Markets(12:40) The Rise of Private Markets and Challenges of Public Markets(18:43) Red Flags in SEC Filings(22:03) The Evolution of Executive Compensation and Elon Musk's Comp(28:53) Egregious Corporate Governance examples: Sketchers.(30:08) The problem of Related Party Transactions.(31:37) Independence and Compensation of Board Members (32:36) Quote of Charlie Munger and Warren Buffett on this topic(36:33) Are we in a AI bubble? Similarities with Enron/Worldcom era? (40:18) Reference to my article on AI washing(41:43) The Importance of SEC Changes (only 3 commissioners from a single party)(43:22) The Role of Markets in Everyday Life(47:45) Books that have greatly influenced her life:The Jungle by Upton Sinclair (1906)Germinal by Émile Zola (1885)Crying in H Mart by Michelle Zauner (2021)(48:20) Her mentors: Nell Minow, Diana Henriques, and Thornton O'Glove.(49:19) Quotes that she thinks of often or lives her life by: "Don't Postpone Joy"(50:52) An unusual habit or an absurd thing that she loves. Michelle Leder is the founder and editor-in-chief of footnoted.com, a source for uncovering important information hidden deep in SEC filings.  You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462 Overview: In this episode, we examine migraine—a leading cause of disability worldwide that is often underdiagnosed and undertreated in primary care. You'll learn how to distinguish migraine from other headache disorders, identify who is most affected, and explore both acute pharmacologic options and preventive strategies that can reduce attack frequency and improve patients' quality of life. Episode resource links: El Hussein, M. T., & Fraser, L. (2025). Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide. The Journal for Nurse Practitioners, 21(9), 105501. Qaseem, A., Tice, J. A., Etxeandia-Ikobaltzeta, I., Wilt, T. J., Harrod, C. S., Cooney, T. G., ... & Yost, J. (2025). Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guideline from the American College of Physicians. Annals of internal medicine, 178(4), 571-578. Charles, A. C., Tepper, S. J., & Ailani, J. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache: The Journal of Head and Face Pain. Vélez-Jiménez MK, et al. Comprehensive Preventive Treatments for Episodic Migraine: Systematic Review. Front Neurol. 2025 Lanteri-Minet, M., Casarotto, C., Bretin, O., Collin, C., Gugenheim, M., Raclot, V., ... & Lefebvre, H. (2025). Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. The Journal of Headache and Pain, 26(1), 153. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Peter Robbins returns to the show, and we talk about his return to the UK and Rendlesham, and then get into the life and research of Wilhelm Reich. If you are not familiar with the man, you should be. You will see why on this show. Peter is of course best known for his work on the Rendlesham Forest case, but has an extensive resume dealing with Reich as well. Peter Robbins was first introduced to the books of Wilhelm Reich as a teenager by a college roommate, to whom he remains deeply indebted. In 1976 he met Dr. Elsworth F. Baker, Reich's first assistant for the last eleven years of his life. Soon after this he became a patient of Dr. Baker and entered into almost seven years of medical orgone therapy with the distinguished orgonomist.Robbins went on to enroll in the classes New York University offered in scientific and social orgonomy which was taught by the Reich scholars Professors John Bell and Paul Matthews. They in turn invited him to become a member of their ongoing Seminar in Social and Scientific Orgonomy, patterned after the seminars which Sigmund Freud presided over during the nineteen twenties. Peter spent much of the nineteen eighties involved with this group, presenting a variety of papers to his fellow seminar members under Matthews' and Bell's guidance and leadership.Peter was a volunteer fundraiser for the American College of Orgonomy's (ACO) Building Fund and had two papers on Wilhelm Reich and UFOs published in the Journal of Orgonomy. He was part of a select group of volunteers invited to witness a demonstration of cloudbusting technology and presented on the subject of Reich and UFOs at the ACO's Princeton NJ facility, and at international conferences on the life and work of Reich in New York City, Ashland Oregon, Niece France and Karavomilos Greece. His lectures have been well received at numerous scientific and UFO conferences both here and abroad while his articles on the subject have been published in a variety of print and web publications. Robbins' extensively researched paper, “Politics, Religion and Human Nature: Practical Problems and Roadblocks on the Path Toward Official UFO Acknowledgment” is scheduled to be published in the upcoming issue of Annals of the Institute for Orgonomic Science. Hosted on Acast. See acast.com/privacy for more information.

In this episode, the CardioNerds (Dr. Naima Maqsood, Dr. Akiva Rosenzveig, and Dr. Colin Blumenthal) are joined by renowned educator in electrophysiology, Dr. Joshua Cooper, to discuss everything atrial flutter; from anatomy and pathophysiology to diagnosis and management. Dr. Cooper's expert teaching comes through as Dr. Cooper vividly describes atrial anatomy to provide the foundational understanding to be able to understand why management of atrial flutter is unique from atrial fibrillation despite their every intertwined relationship. A foundational episode for learners to understand atrial flutter as well as numerous concepts in electrophysiology. Audio editing for this episode was performed by CardioNerds intern Dr. Bhavya Shah.  CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls "The biggest mistake is failure to diagnose”. Atrial flutter, especially with 2:1 conduction, is commonly missed in both inpatient and outpatient settings so look carefully at that 12-lead EKG so you can mitigate the stroke and tachycardia induced cardiomyopathy risk  Decremental conduction of the AV node makes it more challenging to rate control atrial flutter than atrial fibrillation  Catheter Ablation is the first line treatment for atrial flutter and is highly successful, but cardioversion can be utilized as well prior to pursuing ablation in some cases.  Class I AADs like propafenone and flecainide may stability the atrial flutter circuit by slowing conduction and thus may worsen the arrhythmia. Therefore, the preferred anti-arrhythmic medication in atrial flutter are class III agents.  Atrial flutter can be triggered by firing from the left side of the heart, so in patients with both atrial fibrillation and flutter, ablating atrial fibrillation makes atrial flutter less likely to recur.  BONUS PEARL: Dr. Cooper's youtube video on atrial flutter is a MUST SEE!  Notes Notes: Notes drafted by Dr. Akiva Rosenzveig  What are the distinguishing features of atrial fibrillation and flutter?  Atrial flutter is an organized rhythm characterized by a wavefront that continuously travels around the same circuit leading to reproducible P-waves on surface EKG as well as a very mathematical and predictable relationship between atrial and ventricular activity  Atrial fibrillation is an ever changing, chaotic rhythm that consists of small local circuits that interplay off each other. Consequently, no two beats are the same and the relationship between the atrial activity and ventricular activity is unpredictable leading to an irregularly irregular rhythm  What are common atrial flutter circuits?  Cavo-tricuspid isthmus (CTI)-dependent atrial flutter is the most common type of flutter. It is characterized by a circuit that circumnavigates the tricuspid valve.  Typical atrial flutter is characterized by the circuit running in a counterclockwise pattern up the septum, from medial to lateral across the right atrial roof, down the lateral wall, and back towards the septum across the floor of the right atrium between the IVC and the inferior margin of the tricuspid valve i.e. the cavo-tricuspid isthmus. Surface EKG will show a gradual downslope in leads II, III, and AvF and a rapid rise at end of each flutter wave.   Atypical CTI-dependent flutter follows the same route but in the opposite direction (clockwise). Therefore, we will see positive flutter waves in the inferior leads   Mitral annular flutter is more commonly seen in atrial fibrillation patients who've been treated with ablation leading to scarring in the left atrium.  Roof-dependent flutter is characterized by a circuit that travels around left atrium circumnavigating a lesion (often from prior ablation), traveling through the left atrial roof, down the posterior wall, and around the pulmonary veins  Surgical/scar/incisional flutter is seen in people with a history of prior cardiac surgery and have iatrogenic scars in right atrium due to cannulation sites or incisions  How does atrial flutter pharmacologic management differ from other atrial arrhythmias?  The atrioventricular (AV) node is unique in that the faster it is stimulated, the longer the refractory period and the slower it conducts. This characteristic is called decremental conduction. In atrial fibrillation, the atrial rate is so fast that the AV node becomes overwhelmed and only lets some of those signals through to the ventricles creating an irregular tachycardia but at lower rates. In atrial flutter, the atrial rate is slower, therefore the AV node has more capability to conduct allowing for higher ventricular rates. Therefore, to achieve rate control one will need a higher dose of AV blocking medications. Atrial tachycardia may require even higher doses due to the increased ability of the AV node to conduct, as the atrial rates are slower than in atrial flutter.  Sodium channel blockers (Class I) such as flecainide and propafenone slow wavefront propagation, making it easier for the AV node to handle the atrial rates. This will end up leading to increased ventricular rates which can be dangerously fast. That is why AV nodal blockers should be used in conjunction with flecainide and propafenone.  What is the role of cardioversion in atrial flutter management?  Due to high success rate with atrial flutter ablation, ablation is the first line treatment. However, sometimes cardioversion may be utilized in patients depending on how symptomatic they are and how long it will take to get an ablation. Cardioversion may also be utilized preferentially when the atrial flutter was triggered by infection or cardiac surgery to see if it will come back.   If cardioversion is pursued, the patient will need to be anticoagulated due to the stroke risk after the procedure due to post-conversion stunning.  How effective is atrial flutter ablation?  The landmark Natale et al study in 2000 demonstrated 80% success rate after radiofrequency ablation as compared to 36% in patients on anti-arrhythmic therapy. The LADIP study in 2006 further corroborated these findings. Contemporary data shows above 90% success rate of atrial flutter ablation.  In patients who have had both atrial fibrillation and atrial flutter, most electrophysiologists would ablate both. However, in patients with atrial fibrillation, the atrial flutter usually is initiated by trigger spots firing in the left atrium. Once the atrial fibrillation is ablated, the flutter will become less likely. Therefore, there are those who say there's no need to ablate the flutter circuit as well. Alternatively, if a patient has severe comorbidities and/or is high risk for ablation, one may consider performing the atrial flutter ablation only since atrial flutter is harder to manage medically compared with atrial fibrillation.   How do you manage atrial flutter in the acute inpatient setting?  In the inpatient setting, electrical cardioversion is often limited by blood pressure and the hypotensive effects of the sedatives required. If one is awake and too hypotensive, chemical cardioversion can be pursued. The most effective anti-arrhythmic for this is ibutilide. Amiodarone is not effective for acute cardioversion. Since ibutilide prolongs refractoriness in atrial and ventricular tissue, there's a risk of long QT induced torsades de pointes. Pretreating with magneisum reduces the risk to 1-2%.  References Jolly WA, Ritchie WT. Auricular flutter and fibrillation. 1911. Ann Noninvasive Electrocardiol. 2003;8(1):92-96. doi:10.1046/j.1542-474x.2003.08114.x  McMichael J. History of atrial fibrillation 1628-1819 Harvey - de Senac - Laënnec. Br Heart J. 1982;48(3):193-197. doi:10.1136/hrt.48.3.193  Lee KW, Yang Y, Scheinman MM; University of Califoirnia-San Francisco, San Francisco, CA, USA. Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol. 2005;30(3):121-167. doi:10.1016/j.cpcardiol.200  2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e167. doi:10.1161/  Cosío F. G. (2017). Atrial Flutter, Typical and Atypical: A Review. Arrhythmia & electrophysiology review, 6(2), 55–62. https://doi.org/10.15420/aer.2017.5.2  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-11/Atrial-flutter-common-and-main-atypical-forms Natale A, Newby KH, Pisanó E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000;35(7):1898-1904. doi:10.1016/s0735-1097(00)00635-5  Da Costa A, Thévenin J, Roche F, et al. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation. 2006;114(16):1676-1681. doi:10.1161/CIRCULATIONAHA.106.638395  https://www.acc.org/Membership/Sections-and-Councils/Fellows-in-Training-Section/Section-Updates/2015/12/15/16/58/Atrial-Fibrillation#:~:text=The%20first%20'modern%20day'%20account,in%20open%20chest%20animal%20models.&text=In%201775%2C%20William%20Withering%20first,(purple%20foxglove)%20in%20AFib.

Last week Cyprus and Lebanon signed a long-awaited maritime demarcation deal, an agreement that not only paves the way for potential exploration and energy cooperation, but also checks Turkey's revisionist “Blue Homeland” doctrine in the Eastern Mediterranean. Constantinos Filis, the director of the Institute of Global Affairs and a professor of international relations at the American College of Greece, joins Thanos Davelis as we look into what's being called a “historic” deal that also serves to bridge the EU with the Middle East.You can read the articles we discuss on our podcast here:Cyprus–Lebanon deal sets new legal line in the Eastern Med, and Ankara isn't loving itLebanon, Cyprus sign maritime deal, paving way for possible energy explorationGreece, Bulgaria and Romania sign agreement on Aegean-Black Sea corridorCyprus pledges Ukraine will be ''front and center” during EU presidency

In this episode, Guy talked with Dr. Nisha Manek. She challenges conventional understandings of consciousness and delves into the intersection of science and spirituality. Emphasizing that consciousness is not a product of the brain, Nisha discussed the latent capacities of human beings and the need to elevate our levels of conscious awareness. Through her experiences as a medical doctor and her studies with physicist William Tiller, she explored the potential of intention to affect physical reality, the limitations of modern medicine, and the importance of inner work. Nisha also shared practical advice on meditation and the transformative power of silence. About Dr. Nisha: Nisha Manek is an internally recognized leader in the field of integrative medicine. Nisha's humble background from Kenya propelled her to transcend limitations: gender, ethnicity, and financial status. From Case Western Reserve University in Cleveland, Ohio, where she graduated Summa cum laude, to the University of Glasgow School of Medicine in Scotland, Nisha's uncommon tenacity has driven her to ask difficult questions and pursue answers beyond traditional medical paradigms.  Nisha began her career in rheumatology at the Mayo Clinic in Rochester, Minnesota. Recognized as Teacher of the Year in the School of Medicine, she brings storytelling as a core skill to bedside medical teaching and on the plenary stage.  But she didn't stop there. Nisha partnered with one of the world's most innovative physicists, Emeritus Professor William A. Tiller of Stanford University, and pushed the boundaries of what is possible in medicine. She is the preeminent doctor of information medicine, which intersects consciousness, biofield science, and rheumatology to improve human health.  She has authored a one-of-a-kind book, Bridging Science and Spirit, which closes the gap between two seemingly separate areas of knowledge. She is a fellow of the American College of Physicians and a fellow of the Royal College of Physicians of the United Kingdom. Key Points Discussed:  (00:00) - The Hidden Science of Consciousness They Never Taught Us! (00:41) - Welcome to the Podcast (01:11) - The Seeker of Truth (01:43) - Straying from the Truth (02:57) - The Invisible Essence of Consciousness (04:46) - Bridging Science and Spirit (07:25) - The Role of Intention in Medicine (08:07) - The Human Behind the Technology (09:42) - The Power of Consciousness and Intention (12:59) - Meeting William Tiller (22:59) - The Experiment with Water (26:40) - The Unique Feel of Different Spaces (27:13) - The Sacredness of Tiller's Lab (27:49) - Bridging Science and Spirit (29:11) - The Power of Intention and Energy (32:11) - The Potential of Human Consciousness (39:51) - Daily Practices for Consciousness (49:05) - Reflections and Personal Journey (51:09) - Final Thoughts and Book Information How to Contact Dr. Nisha Manek:www.nishamanekmd.com   About me:My Instagram: www.instagram.com/guyhlawrence/?hl=en Guy's websites:www.guylawrence.com.au www.liveinflow.co''

This episode features William E. Cohn, MD, FACS, a cardiothoracic surgeon from Houston, Texas, who delivered the I. S. Ravdin Lecture during the American College of Surgeons (ACS) Clinical Congress in Chicago. In his lecture, “The Past, Present, and Future of the Total Artificial Heart,” Dr. Cohn not only explored the history of artificial heart innovation but also the paradigm-shifting work that may finally bring a permanent solution for end- stage heart failure. Talk about the podcast on social media using the hashtag #HouseofSurgery

Are the Pollutant Levels in Fish High Enough to Be Harmful? The tolerable daily toxin safety limits are based on single chemicals. What if "safe" levels of chemicals in seafood are combined and tested together? Listen to today's episode written by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #plantbasedbriefing #fish #fishing #seafood #toxins #environmentaltoxins #toxicbioaccumulation ================== Original post: https://nutritionfacts.org/video/are-the-pollutant-levels-in-fish-high-enough-to-be-harmful  ================== Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity. ============================== FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/     

Advisors everywhere are feeling the pressure to scale, hire, and prepare for a wave of retirements that will reshape the industry. At the same time, firms are struggling to attract women, keep next-gen advisors engaged, and build teams that actually create freedom instead of more work.That's why I wanted to bring Lindsey Lewis on the show. After building a $200M book in her first year at Vanguard, Lindsey shifted her career toward research at The American College so she could help the profession fix its biggest blind spots—especially around women in finance, advisor retention, and the future talent pipeline.We dig into the data shaping the next decade of financial services: what women uniquely bring to advisory firms, why Gen Z is more interested in this profession than any generation before them, and how training, compensation, and career clarity determine whether young advisors stay or disappear.4 of the biggest insights from Lindsey …#1.) The Biggest Talent Gap in Advisor HistoryWe're staring down a generational shift in this profession. Tens of thousands of advisors are aging out. And when you run the math, the industry would need to hire over a million new people just to meet today's demand. Lindsey walks through the data behind this massive workforce gap and why the firms who build real training, career paths, and development now will be miles ahead of everyone else over the next decade.#2.) Women Advisors Are a Huge Missed OpportunityThe numbers don't lie: women make up 25% of CFPs… but only a small fraction are in sales/growth positions. And it's not a talent issue, it's how the industry has shaped roles, pay structures, and expectations over time. Lindsey breaks down why women often outperform in retention, personalization, referrals, and relationship depth, yet get pushed into service tracks or stay risk-averse because of cultural narratives, confidence gaps, or biases inside firms. The upside for the firms who fix this is enormous. Women represent one of the biggest untapped growth engines in financial services.#3.) Gen Z Wants In, But Poor Onboarding Pushes Them OutHere's the part no one expects: financial services is now Gen Z's top-preferred industry over tech and medicine. But at the same time, 1 in 4 early-career advisors say their onboarding wasn't effective — and those are the same people who leave within seven years. Lindsey lays out exactly what this generation needs to stay: mentorship, sponsorship, clear career paths, ongoing education, and roles that evolve with their confidence. If you want a talent pipeline that sticks, it starts with the first 12–18 months.#4.) Compensation Makes or Breaks Your TeamComp plans aren't just about money, they're about psychology. Young advisors need stability before they're ready to take on variable comp. Others crave upside and hate the idea of a flat salary. Lindsey explains the difference between income risk tolerance and income risk capacity, and why misalignment between the person and the pay structure is one of the biggest drivers of turnover. When firms get comp wrong, they churn through talent. When they get it right, people stay, grow, and eventually step into the very roles the industry is desperate to fill. SHOW NOTEShttps://bradleyjohnson.com/145FOLLOW BRAD JOHNSON ON SOCIALTwitterInstagramLinkedInFOLLOW DBDL ON SOCIAL:YouTubeTwitterInstagramLinkedInFacebookDISCLOSURE DBDL podcast episode conversations are intended to provide financial advisors with ideas, strategies, concepts and tools that could be incorporated into their business and their life. No statements made in the episode are offered as, and shall not constitute financial, investment, tax or legal advice. Financial professionals are responsible for ensuring implementation of anything discussed related to business is done so in accordance with any and all regulatory, compliance responsibilities and obligations. The Triad member statements reflect their own experience which may not be representative of all Triad Member experiences, and their appearances were not paid for. Triad Wealth Partners, LLC is an SEC Registered Investment Adviser. Please visit Triadwealthpartners.com for more information. Triad Wealth Partners, LLC and Triad Partners, LLC are affiliated companies. TP11254981366See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Are Environmental Toxins Lower in Wild-Caught or Farmed Fish? The adverse effects of industrial pollutants in seafood may counteract the benefits of nutrients in fish. Listen to today's episode written by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #plantbasedbriefing #fish #fishing #seafood #toxins #environmentaltoxins #toxicbioaccumulation ================== Original post: https://nutritionfacts.org/video/are-environmental-toxins-lower-in-wild-caught-or-farmed-fish/  ================== Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity. ============================== FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/     

In this powerful and deeply personal episode, we are honored to welcome Major General (Retired) David Rubenstein, the 16th Chief of the U.S. Army Medical Service Corps and former Deputy Surgeon General of the Army. With 35 years of active-duty service, including 12 years in command, MG Rubenstein brings unmatched experience, wisdom, and humility to this rich and engaging conversation. Episode HighlightsThe 14-Word Leadership Philosophy MG Rubenstein shares his simple but powerful career-long philosophy: Take care of people. Take care of equipment. Pay attention to detail. Blend life. He unpacks how this philosophy shaped his command, influenced thousands, and still resonates today across military and civilian leadership.Leadership Lessons from Command From his early days as a platoon leader in Germany to commanding some of the Army's most critical medical organizations, MG Rubenstein reflects on what truly matters: balancing cultures, embracing growth, and leading people with purpose.Ranger School & Resilience Hear how Ranger School developed his attention to detail and leadership under pressure and why he believes all Soldiers should ask for opportunities, even if the answer might be no.Operational vs. TDA Command MG Rubenstein explains why good leadership transcends unit type and that every command matters when you lead with intention and authenticity.Service After Service Learn how MG Rubenstein continues to give back through volunteering, mentoring, and professional society leadership. He breaks down how to start giving back today, whether you're still in uniform or planning for retirement.Mentorship & Asking the Right Questions Discover his take on building genuine mentor relationships and the difference between a mentee and a protégé. MG Rubenstein also shares how just asking one career question can be the start of a transformational connection.Professional Organizations & Lifelong Learning As a past Chairman of the Board of Governors of the American College of Healthcare Executives (ACHE), he explains why belonging to a professional society is critical for continued development and how board certification sets leaders apart.

For this episode listen as hosts Molly, Patricia, and Kaitlin discuss their recommendations for the holiday gifts for the medical student in your life! Don't forget, EM Over Easy is the Official Podcast of the American College of Osteopathic Emergency Physicians. To learn more about this organization and its Resident Student Organization visit acoep.org today!

In Episode 237, in conversation with Dr. Gillian Lockitch, Scott Fulton reframes "successful aging" as more years, more moments, more money. He unpacks his MEDAC model—Mind, Environment, Diet, Activity, Community—and shows how small, practical tweaks compound: design homes for longevity, manage toxin exposure sensibly, eat for quality/variety/fiber, move all day (not just "exercise"), train balance, and build supportive community. They also explore simple ways to measure what matters and why stepping outside your comfort zone is a powerful aging tool. Scott Fulton is a longevity educator and positive-aging innovator whose work sits at the intersection of health and housing. He teaches adult learners about healthspan and aging (Northwestern, UVA, University of Delaware), created the MEDAC system (Mind, Environment, Diet, Activity, Community), is a member of the American College of Lifestyle Medicine and the True Health Initiative Council, and served as President of the National Aging in Place Council. He and his wife live in Charlottesville, VA, in a demonstration home designed for optimal aging.   Timeline: 00:00 – 03:20 | Why "Wealthspan" now Gillian's introduction: aging is inevitable, poor health isn't. Scott's thesis: extend health, life, and financial security—so you can collect more meaningful moments.  03:21 – 09:58 | Designing a home that ages with you One-step entries, wider doors, "free-flow" layouts, smart use of terrain. Beauty + function beats "clinical" design and prevents future injuries/barriers.  09:59 – 18:13 | From big systems to positive aging, Scott's career pivot: apply systems thinking to aging. Against siloed care; for measurable, holistic balance (homeostasis) and innovation that actually changes outcomes.  18:14 – 26:59 | MEDAC: Mind & Environment Stay curious; protect cognition. Shape two environments: your home and your exposures. You can't avoid toxins entirely—reduce risk and diversify behaviors.  27:00 – 31:53 | MEDAC: Diet & Activity Start with quality, add variety, and count fiber. Activity ≠ just workouts: build cardio, strength, balance, and move through the day to fight sedentariness.  31:54 – 40:52 | MEDAC: Community + Resilience & the "one bold thing" rule Social connection protects brain and practical living. Gillian and Scott on mindset, brain training, and choosing something outside your comfort zone to spark growth.  Learn about Scott Fulton and his book. https://www.linkedin.com/in/scottfultonentrepreneur/ https://www.youtube.com/@whealthspan Download your Gift: Guide to Nature's Colourful Antioxidants.  Book a one-on-one call with Dr. Gillian Lockitch    Join the Growing Older Living Younger Community 

For this years Holiday Gift Guide, listen as hosts Drew, Tanner, and Andy work you through their recommendations for anyone on your list. Don't forget, we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org today to learn more about an upcoming CME event!

Episode 207: Understanding Hypertension and Diabetes (Pidjin English)Written by Michael Ozoemena, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.HypertensionSegment 1: What Is Hypertension?HOST:Let's start with the basics. Blood pressure is the force of blood pushing against the walls of your arteries. Think of it like water running through a garden hose—if the pressure stays too high for too long, that hose starts to wear out.Hypertension, or high blood pressure, means this pressure is consistently elevated. It is measured using two numbers:Systolic: the pressure when the heart beatsDiastolic: the pressure when the heart relaxesNormally reading is around 120/80 mmHg. Hypertension is defined by the American College of Cardiology/American Heart Association (ACC/AHA) as 130/80 mmHg or higher.The American Academy of Family Physicians (AAFP) defines hypertension as persistent elevation of systolic and/or diastolic blood pressure, with the diagnostic threshold for office-based measurement set at 140/90 mm Hg or higher.Segment 2: Why Should We Care?HOST:Hypertension is known as “the silent killer” because most people have no symptoms. Even without symptoms, it steadily increases the risk of:Heart attackStrokeKidney diseaseThink of high blood pressure as a constant stress test on your blood vessels. The longer it goes uncontrolled, the higher the chance of complications.Segment 3: What Causes High Blood Pressure?HOST:Hypertension usually doesn't have a single cause. It often results from a combination of genetic factors, lifestyle, and underlying medical conditions.Modifiable FactorsHigh-salt diet and low potassium intakePhysical inactivityTobacco useExcessive alcohol intakeOverweight or obesityChronic stressPoor sleep or sleep apneaNon-Modifiable FactorsFamily history of hypertensionBlack race (higher prevalence and severity)Age over 65Hypertension may also be secondary to other conditions, such as kidney disease, thyroid disorders, adrenal conditions, or medications like NSAIDs or steroids.Segment 4: How Is It Diagnosed?HOST:Diagnosis requires multiple elevated blood pressure readings taken on different occasions. This includes office readings, home blood pressure monitoring, or ambulatory blood pressure monitoring.If you haven't had your blood pressure checked recently, this is your reminder. It's simple—and it could save your life.Segment 5: Treatment and ManagementHOST:Lifestyle changes are often the first line of treatment:Reduce salt intakeEat more fruits, vegetables, and whole grainsAim for 150 minutes of moderate exercise per weekManage stressMaintain a healthy weightGet enough sleepLimit alcoholQuit smokingIf these steps aren't enough, medications may be necessary. These include:Diuretics, ACE inhibitors, ARBs, Calcium channel blockers, Beta-blockersYour healthcare provider will choose the best medication based on your health profile.Segment 6: What You Can Do TodayHOST:Here are three simple, actionable steps you can take right now:Check your blood pressure—at a clinic, pharmacy, or at home.Pay attention to your salt intake—much of it is hidden in processed foods.Move more—even a 20-minute daily walk can help reduce blood pressure over time.Small steps can lead to big, lasting improvements.SummaryHypertension may be silent but understanding it gives you power. Early action can add healthy years to your life. Take charge of your blood pressure today.Diabetes1. Wetin Diabetes Be and Wetin E Go Do to Person Body?Q: Wetin diabetes mean?A: Diabetes na sickness wey make sugar (glucose) for person blood too high. E happen because the body no fit produce insulin well, or the insulin wey e get no dey work as e suppose.Q: Wetin go happen if diabetes no dey treated well?A: If diabetes no dey treated well, e fit damage the blood vessels, nerves, kidneys, eyes, and even the heart.2. Wetin Cause Diabetes and Why Black People Suffer Pass?Q: Wetin cause diabetes?A: E no be one thing wey cause diabetes. E dey happen because of mix of gene, lifestyle, environment, and society factors.Q: Why Black/African Americans get diabetes more?A: Black people for America get diabetes more because of long-standing inequality, stress, low access to healthcare, and the kind environment wey many of them dey live in. These things dey make Black people more at risk.3. Diabetes Rates for America and Black People?Q: How many people get diabetes for America?A: For America today, over 38 million people get diabetes, and the number dey rise every year.Q: Why Black people dey suffer diabetes more than White people?A: About 12% of Black adults get diabetes, compared to just 7% for White adults. Black people also dey get the sickness earlier and e dey more severe.4. Signs and Symptoms of Diabetes?Q: Wetin be the early signs of diabetes?A: The early signs no too strong, but when e show, e fit include:Too much urine (polyuria)Thirst (polydipsia)Hunger, tiredness, and blurred visionWounds no dey heal fastTingling for hand or legSometimes weight loss5. How Doctor Go Diagnose Diabetes?Q: How doctor fit confirm say person get diabetes?A: Doctor go do some lab tests to confirm:Fasting Plasma Glucose (FPG): 126 mg/dL (7.0 mmol/L) or higherHbA1c: 6.5% or higher2-hour Oral Glucose Tolerance Test (OGTT): 200 mg/dL (11.1 mmol/L) or higher after person drink glucose.Random Blood Glucose: 200 mg/dL (11.1 mmol/L) or higher plus classic symptoms like too much urination, thirst, or weight loss.Q: Wetin happen if HbA1c test no match the person?A: If HbA1c result no match person symptoms, doctor fit repeat test or try other tests like FPG or OGTT.6. Wetin Screening and Early Diagnosis Fit Do?Q: Why screening for diabetes dey important?A: Screening dey important because early detection fit prevent serious complications from diabetes.Q: How often person go do diabetes test?A: Adults wey get overweight or obesity, between 35–70 years, suppose do diabetes screening every three years. But because Black adults get higher risk, doctors dey start screening earlier and more often.7. How Person Fit Manage Diabetes?Q: Wetin be the best way to manage diabetes?A: The two main ways to manage diabetes be:Lifestyle changes: Eat better food (vegetables, fruits, whole grain, beans, fish, chicken) and exercise regularly.Medicine: If person sugar still high, doctor fit give drugs like metformin, SGLT-2 inhibitors, or GLP-1 receptor agonists.Q: Wetin be SGLT-2 inhibitors and GLP-1 drugs?A: SGLT-2 inhibitors dey help with kidney and heart problems, while GLP-1 drugs dey help with weight loss and prevent stroke.Q: Wetin be first-line treatment for diabetes?A: First-line treatment for diabetes be metformin, unless person no fit tolerate am.Q: How much exercise a person suppose do?A: Person suppose do at least 150 minutes of moderate exercise per week. This fit include things like brisk walking, swimming, or cycling. E also good to add muscle-strength training two or three times weekly to help control sugar.Q: When insulin therapy go be needed?A: Insulin therapy go be needed if person A1c is higher than 10%, or if person dey hospitalized and their glucose dey above the 140-180 range. This go help bring the blood sugar down quickly.8. Wetin Be the Complications of Diabetes?Q: Wetin fit happen if diabetes no dey well-managed?A: Complications fit include kidney disease, blindness, nerve damage, leg ulcers, heart attack, stroke, and emotional issues like depression.Q: Why Black adults get more complications?A: Black people get higher risk of these complications because of inequality, stress, and poor access to healthcare.9. Wetin Dey Affect Access to Diabetes Treatment?Q: Wetin make Black people struggle to get treatment for diabetes?A: Many Black people no dey get new effective treatments like GLP-1 and SGLT-2 inhibitors because of price, insurance issues, and lack of access. COVID-19 also worsen things.Q: Wetin government and doctors fit do?A: Policymakers dey work on improving access to drugs, better community programs, and screening for social issues wey fit affect diabetes care.10. ConclusionQ: Wetin be the solution to reduce diabetes impact?A: The solution go need medical treatment, early screening, lifestyle support, and policy changes. With proper treatment and community support, e possible to reduce the impact of diabetes, especially for Black communities.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References: Whelton PK, Carey RM. Overview of hypertension in adults. UpToDate. 2024.Carey RM, Moran AE. Evaluation of hypertension. UpToDate. 2024.Mann SJ, Forman JP. Lifestyle modification in the management of hypertension. UpToDate. 2024.Giles TD, Weber MA. Initial pharmacologic therapy of hypertension. UpToDate. 2024.American Heart Association. Understanding Blood Pressure Readings. Accessed 2025.American Heart Association. AHA Dietary and Lifestyle Recommendations. Accessed 2025.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Recurrent pregnancy loss (RPL) affects approximately 5% of couples and is an emotional burden on those affected. There is some evidence that vaginal progesterone supplementation may be considered in patients with recurrent pregnancy loss who are experiencing vaginal bleeding during the first trimester. But what about prophylactic low dose aspirin in the first trimester, or preconceptionally, for unexplained RPL? Is that evidence-based? A new publication from the SMFM's journal Pregnancy has examined this. Listen in for details. 1. 22 November 2025: Low-dose aspirin in unexplained recurrent pregnancy loss: A systematic review and meta-analysis (Pregnancy): https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pmf2.700992. American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, T. Flint Porter, Cynthia Gyanff-Bannerman, Tracy Manuck. Low-Dose Aspirin Use During Pregnancy. American College of Obstetricians and Gynecologists (2018)3. Naimi AI, Perkins NJ, Sjaarda LA, et al. The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial. Annals of Internal Medicine. 2021;174(5):595-601. doi:10.7326/M20-0469.4. Lee EE, Jun JK, Lee EB.Management of Women With Antiphospholipid Antibodies or Antiphospholipid Syndrome During Pregnancy. Journal of Korean Medical Science. 2021;36(4):e24. doi:10.3346/jkms.2021.36.e24.5. de Assis V, Giugni CS, Ros ST. Evaluation of Recurrent Pregnancy Loss. Obstet Gynecol. 2024 May 1;143(5):645-659. doi: 10.1097/AOG.0000000000005498. Epub 2024 Jan 4. PMID: 38176012.

Dr. Rosensweet graduated from the University of Michigan Medical School in 1968. Since 1971, he has been in private medical practice, with offices in Florida, New Mexico, California, and Colorado. Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico.He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.”Dr. R is the Founder of The Menopause Method and The Institute of BioIdentical Medicine, where he has been training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women. More about Dr. Rosensweet:* Was recently named one of “The Biggest Names in Anti-Aging Medicine” by The American Academy of Anti-Aging Medicine (A4M)* Author of the books, Menopause and Natural Hormones and Happy Healthy Hormones: How to Thrive in Menopause* Founder of Brite (www.brite.live) and I Wonder, Doctor… (www.iwonderdoctor.com)* Founder and co-chair of the Coalition to Protect Compounded Bioidentical Hormones (cbhrtcoalition.org)*Organizer of a National Summit Committee on the Treatment of Women in Menopause with Bioidentical Hormones* Principal Investigator for a scientific study of female hormones.https://brite.live/       https://iobim.org       https://www.davedrosensweetmd.comhttps://www.facebook.com/share/g/1CEpiqShxB/https://www.instagram.com/menopausedoctor?utm_source=ig_web_button_share_sheet&i“I recommend this product to my clients for hemorrhoids, fissures, itching, irritation, dryness and for any kind of butt drama. I like it because it's all-natural, soothing, effective, multi-purpose and female founded. It's made with healing ingredients such as arnica, vitamin e oil, organic aloe and the branding speaks for itself.” Use code VAGINACOACH to save 20% at www.anythingbrands.comThank you so much for listening! I use fitness and movement to help women prevent and overcome pelvic floor challenges like incontinence and organ prolapse. There is help for women in all life stages! Every Woman Needs A Vagina Coach! Please make sure to LEAVE A REVIEW and SUBSCRIBE to the show for the best fitness and wellness advice south of your belly button. *******************I recommend checking out my comprehensive pelvic health education and fitness programs on my Buff Muff AppYou can also join my next 28 Day Buff Muff Challenge https://www.vaginacoach.com/buffmuffIf you are feeling social you can connect with me… On Facebook https://www.facebook.com/VagCoachOn Instagram https://www.instagram.com/vaginacoach/On Twitter https://twitter.com/VaginaCoachOn The Web www.vaginacoach.comGet your Feel Amazing Vaginal Moisturizer Here

Discover how artificial intelligence is revolutionizing heart disease prevention and treatment with Dr. Ami Bhatt, Chief Innovation Officer at the American College of Cardiology.From AI-powered early detection tools to personalized risk prediction, learn how new technologies are making quality cardiac care more accessible while preserving the essential human element of medicine. Dr. Bhatt shares fascinating insights about the innovations transforming cardiovascular health today and her vision for even more remarkable advances coming in the next five years.You can find Ami at: Website | LinkedIn | Episode TranscriptIf you LOVED this episode, don't miss a single conversation in our Future of Medicine series, airing every Monday through December. Follow Good Life Project wherever you listen to podcasts to catch them all.Check out our offerings & partners: Join My New Writing Project: Awake at the WheelVisit Our Sponsor Page For Great Resources & Discount Codes Hosted on Acast. See acast.com/privacy for more information.

(0:00) Intro(1:30) About the podcast sponsor: The American College of Governance Counsel(2:16) Start of interview(3:01) Erik's origin story(6:10) His role at the Tippie College of Business at the University of Iowa.(7:49) Exploring his book Catching Cheats(9:39) About the field of forensic economics(11:00) The Challenge of Private Market Data and Fraud *Reference to our Startup Litigation Digest(16:24) Board Responsibilities in Fraud Detection(19:03) Challenges for private company boards(21:22) Insights and red flags from the Madoff Case(26:30) Insider Trading and Its Challenges(31:29) The Role of Whistleblowers in Fraud. Reference to E142 with Tyler Shultz and E130 with Mary Inman (whistleblower attorney)(35:44) Cultural Perspectives on White-Collar Crime(39:59) The Intersection of Vision and Fraud(41:27) Fraud problems in academia(44:00) The Impact of AI on Fraud Dynamics *suggested read: The Trillion Dollar Governance Reckonings(49:46) The role of directors in the stock backdating scandals "they were happy beneficiaries"(51:03) Books that have greatly influenced his life:Animal Farm by George Orwell (1945)Into Thin Air by Jon Krakauer (1997)(53:45) His mentors *discussion about the Norges Bank Investment Mgmt Fund ($2T AUM) and its ethical issues.(56:23) Quotes that she thinks of often or lives her life by.(57:10) An unusual habit or an absurd thing that she loves. (58:08) The living person he most admires: Bill Gates.Erik Lie is the Amelia Tippie Chair in Finance and Professor at the Tippie College of Business at the University of Iowa. His new book, Catching Cheats: Everyday Forensics to Unmask Business Fraud, offers a compelling look at how forensic economics and data-driven analysis can help identify wrongdoing that remains hidden in plain sight.  You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

If you're in the middle of a divorce and constantly asking yourself “WHY is this happening?”, this episode is about to save you money, misery, and a whole lot of emotional tailspinning.This week, Andrea and Morgan dive deep into the question that can either move your divorce forward—or completely derail you: WHY.When is asking why strategic?And when is it a waste of attorney fees (or your sanity)?To help break it all down, we're joined by Cary J. Mogerman, one of the most respected divorce attorneys in Missouri. Cary brings decades of experience, a wise-professor vibe, and a no-nonsense approach to helping clients understand the process clearly, calmly, and strategically.Cary J. Mogerman is one of the most highly regarded divorce lawyers in Missouri and wellknown to other top family law attorneys throughout the United States. He is a Fellow of the American Academy of Matrimonial Lawyers and in 2022, served as President of the national organization. He is a Diplomate of the American College of Family Trial Lawyers, an invitation-only assemblage limited to 100 members throughout the United States; Cary is a member of its executive committee. He is a Fellow of the International Academy of Family Lawyers.https://carmodymacdonald.com/people/cary-j-mogerman/In this conversation, you'll learn:Why “Why is this happening to me?” is a therapist question—not a lawyer questionHow to ask WHY in a way that strengthens your strategy, saves money, and reveals leverageWhy understanding your spouse's emotional triggers can completely shift mediationThe one communication mistake clients make that drives lawyers insaneWhen your lawyer should break things down in plain languageWhy slowing down your responses (yes, YOU) will prevent disasterHow to stop burning money on the wrong kind of questionsWhy the legal process feels slow, confusing, and unfair—and what to do with thatHow to advocate for yourself without apologizingPLUS: Andrea reveals a HUGE co-parenting milestone (Shabbat dinner with the ex… yes, seriously), and Morgan talks through why listeners were so triggered by last week's episode—and what that means for your own healing.This is the episode you NEED if you're negotiating, mediating, litigating, co-parenting, or just trying to get through the day without rage-texting your ex or panic-emailing your lawyer.Key Takeaways1. Not All “Why” Questions Are Helpful“Why is this happening?”“Why is he acting like this?”“Why is she being crazy?”These are human questions—but not legal ones.They belong in therapy, not in your billable hours.2. Strategic Why's Are POWERFULWhy are we filing this motion?Why is this our mediation plan?Why is my ex reacting this strongly to ONE issue?These help your attorney build a smarter, more effective case.3. Your Lawyer Should Explain Everything in Plain LanguageCary breaks down why attorneys NEED to simplify their communication—and why you should never feel embarrassed asking:“Can you explain that in normal-person English?”4. Your Spouse's Triggers = Your StrategyYou know your spouse better than anyone.Your insights help your attorney negotiate smarter and faster.5. Don't Make Split-Second Decisions During Emotional SurgesYou're not being chased by a bear.Slow down. Breathe. Don't respond immediately.You can literally save thousands of

Step outside the operating room with us to explore the art, creativity, and humanism that shape a surgeon's life beyond medicine. Our guest Dr. Adnan Alseidi is not only a renowned hepatobiliary surgeon and surgical educator, but also an avid diver, photographer, and chef. Dr. Alseidi takes us from World War 2 shipwrecks to his restaurants around the world, reflecting on the fragility of humanity revealed in the oceans and moments of connection simmering in the kitchen. Along the way, he shares how creativity, service, and humility fuel his passions and his practice. Join hosts Pooja Varman, MD, Judith French, PhD, and Jeremy Lipman, MD, MHPE, for this inspiring conversation about finding joy and connection in and beyond surgical practice. Learning Objectives By the end of this episode, listeners will be able to  1.     Describe the ways in which creative pursuits can deepen a surgeon's perspective on medicine and life. 2.     Identify parallels between artistry and surgery, including precision, patience, and respect for human fragility. 3.     Discuss strategies for maintaining balance and encouraging trainees to integrate creativity into their professional identities. References 1.     Executive Leadership Program in Health Policy and Management at Brandeis University, sponsored by the American College of Surgeons and several co-sponsoring organizations. 2.     The Book of Joy, by Dalai Lama, Desmond Tutu, and Douglas Carlton Abrams 3.     Dr. Alseidi's Wildlife Photography Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

CardioNerds (Dr. Kelly Arps, Dr. Naima Maqsood, and Dr. Elizabeth Davis) discuss chronic AF management with Dr. Edmond Cronin. This episode seeks to explore the chronic management of atrial fibrillation (AF) as described by the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. The discussion covers the different AF classifications, symptomatology, and management including medications and invasive therapies. Importantly, the episode explores current gaps in knowledge and where there is indecision regarding proper treatment course, as in those with heart failure and AF. Our expert, Dr. Cronin, helps elucidate these gaps and apply guideline knowledge to patient scenarios. Audio editing for this episode was performed by CardioNerds intern Dr. Bhavya Shah. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Review the guidelines- Catheter ablation is a Class I recommendation for select patient groups  Appropriately recognize AF stages- preAF conditions, symptomatology, classification system (paroxysmal, persistent, long-standing persistent, permanent)  Be familiar with the EAST-AFNET4 trial, as it changed the approach of rate vs rhythm control  Understand treatment approaches- lifestyle modifications, management of comorbidities, rate vs rhythm control medications, cardioversion, ablation, pulmonary vein isolation, surgical MAZE  Sympathize with patients- understand their treatment goals  Notes Notes: Notes drafted by Dr. Davis.    What are the stages of atrial fibrillation?   The stages of AF were redefined in the 2023 guidelines to better recognize AF as a progressive disease that requires different strategies at the different therapies  Stage 1 At Risk for AF: presence of modifiable (obesity, lack of fitness, HTN, sleep apnea, alcohol, diabetes) and nonmodifiable (genetics, male sex, age) risk factors associated with AF  Stage 2 Pre-AF: presence of structural (atrial enlargement) or electrical (frequent atrial ectopy, short bursts of atrial tachycardia, atrial flutter) findings further pre-disposing a patient to AF  Stage 3 AF: patient may transition between these stages  Paroxysmal AF (3A): intermittent and terminates within ≤ 7 days of onset  Persistent AF (3B): continuous and sustained for > 7 days and requires intervention  Long-standing persistent AF (3C): continuous for > 12 months   Successful AF ablation (3D): freedom from AF after percutaneous or surgical intervention  Stage 4 Permanent AF: no further attempts at rhythm control after discussion between patient and clinician   The term chronic AF is considered obsolete and such terminology should be abandoned   What are common symptoms of AF?   Symptoms vary with ventricular rate, functional status, duration, and patient perception  May present as an embolic complication or heart failure exacerbation  Most commonly patients report palpitations, chest pain, dyspnea, fatigue, or lightheadedness. Vague exertional intolerance is common  Some patients also have polyuria due to increased production of atrial natriuretic peptide  Less commonly can present as tachycardia-associated cardiomyopathy or syncope  Cardioversion into sinus rhythm may be diagnostic to help determine if a given set of symptoms are from atrial fibrillation to help guide the expected utility of more aggressive rhythm control strategies.   What are the current guidelines regarding rhythm control and available options?  COR-LOE 1B: In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should be recommended to evaluate whether AF is contributing to the reduced LV function   COR-LOE 2a-B: In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should be recommended to evaluate whether AF is contributing to the reduced LV function. In patients with a recent diagnosis of AF (

Join Elevated GP: www.theelevatedgp.com Net32.com  Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram His interdisciplinary approach to dentistry is founded in both empirical research and clinical experience. He attended the University of Washington for both his undergraduate and graduate studies where he received his D.D.S. degree in 1995 and an M.S.D. and certificate in Prosthodontics in 1998. For his entire career, Dr. Kinzer has been committed to furthering the art and science of dental education. His unique ability to impart complex clinical processes in a logical, systematic and clear methodology differentiates him from other Prosthodontists and makes him a highly regarded educator nationally and internationally. He is a full-time teaching faculty at Spear Education in Scottsdale, AZ. where he is also resides as the Faculty Chairman and Director of Curriculum and Campus Education. Dr. Kinzer is an Affiliate Assistant Professor in the Graduate Prosthodontics Department at the University of Washington School of Dentistry and an Adjunct Faculty at Arizona School of Dentistry and Oral Health. Dr. Kinzer is a member of many professional organizations including the American Academy of Restorative Dentistry and the American Academy of Esthetic Dentistry, of which he is currently the sitting President. He serves on the editorial review board for several recognized dental publications and has written numerous articles and chapters for dental publication. He has been honored with the American College of Prosthodontics Achievement Award and in 2018, he received the Saul Schluger Memorial Award for Excellence in Diagnosis and Treatment Planning from the Seattle Study Club. In 2022 he was inducted into the World's Top 100 Doctors as part of the Interdisciplinary Cohort. In his free time, Gregg cherishes spending time his wife Jill and their 6 children. He enjoys anything that he can do outside: golfing, hiking, running, skiing, and biking, in addition to a nice glass of wine.

In this episode, Tom Varghese, MD, FACS, is joined by Ziad Sifri, MD, FACS, from Rutgers New Jersey Medical School, and Matthew Linz, MD, from Rutgers Robert Wood Johnson Medical School. They discuss Drs Sifri and Linz's recent article, “Postoperative Pain Management in the US vs Low- and Middle-Income Countries by US Surgeons,” in which they found that surgeons in the US prescribe significantly more opioids after inguinal hernia repair compared with when they operate on short-term surgical trips to low- and middle-income countries, despite continued efforts to reduce opioid overprescription in the US.   Disclosure Information: Drs Varghese, Linz, and Sifri have nothing to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Linz, Matthew S MD1; Parvin-Nejad, Fatemeh P MD2; Srinivasan, Nivetha MD3; Vegunta, Geetasravya MD1; Eng, Ashley K BS1; Kim, Eugene BA MBS; Alexander, Imani BS1; Elgammal, Fatima MD2; Benson, Ryan MD2; Benneh, Albert Y MD4; Gyakobo, Mawuli K MD5,6; Lopez, Lorena MD7; Jalloh, Samba MD8; Sifri, Ziad C MD FACS2. Postoperative Pain Management in the US vs Low-and-Middle-Income Countries by US Surgeons. Journal of the American College of Surgeons ():10.1097/XCS.0000000000001538, July 30, 2025. | DOI: 10.1097/XCS.0000000000001538   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord

Learn about Form 709-NA, e-filing updates, gift splitting, digital assets, and disclosure rules in this ACTEC podcast on gift tax returns. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.

Earlier this month, more than 2,500 allergists and healthcare professionals gathered in Orlando, Florida, for the annual meeting of the American College of Allergy, Asthma & Immunology—better known as ACAAI. It's one of the biggest events of the year where experts share the latest research, treatments, and guidelines in allergy and immunology. We're thrilled to be joined by this year's keynote speaker, program chair—and FAACT Medical Board Member—Dr. Kristin Sokol, MD, MS, MPH, who shares highlights and key takeaways from this cutting-edge meeting.Resources to keep you in the know:American College of Allergy Asthma and Immunology (ACAAI)Schreiber Allergy: Kristin Sokol, M.D., MS, MPH, FACAAI, FAAAAIYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: GenentechThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

Dr. Muhamad Aly Rifai is a highly respected internist and psychiatrist serving the Greater Lehigh Valley, Pennsylvania. As the CEO and Chief Psychiatrist and Internist of Blue Mountain Psychiatry, he leads with expertise and dedication to mental health and internal medicine. He also holds the distinguished title of Lehigh Valley Endowed Chair of Addiction Medicine, further solidifying his authority in the field.Dr. Rifai is Board Certified in multiple specialties, including Internal Medicine, Psychiatry, Addiction Medicine, and Psychosomatic Medicine, demonstrating his extensive knowledge and commitment to comprehensive patient care. His professional achievements have earned him recognition as a Fellow of the American College of Physicians, the Academy of Psychosomatic Medicine, and the American Psychiatric Association. Additionally, he has served as the President of the Lehigh Valley Psychiatric Society, contributing significantly to the advancement of psychiatric practice in the region.Learn more: http://www.alyrifai.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-dr-muhamad-aly-rifai-ceo-chief-psychiatrist-and-internist-of-blue-mountain-psychiatry